How to Use the USP–NF Errata Table

After line 1 of Column: Add a new section
Column temperature: 70°

Line 5 of Analysis: Change
Result = [r_UA/(Σr_UA + 25r_UB)] × 100
to:
Result = [r_UA/(Σr_UA + 30r_UB)] × 100
AND
Change line 12 of Analysis:
Result = [Σr_UA/(Σr_UA + 25r_UB)] × 100
to:
Result = [Σr_UA/(Σr_UA + 30r_UB)] × 100

In the Note in line 11 of Titration: Change
Rinse the grains by swirling with three 15-mL portions of Purified Water, and add the washings to the main solution.
to:
Rinse the grains by swirling with three 15-mL portions of Carbon Dioxide-Free Water, and add the washings to the main solution.

Line 1 of Test preparation: Change
Use the Assay preparation, prepared as directed in the Assay.
to:
Transfer about 69 mg of Aminosalicylate Sodium, accurately weighed, to a 100-mL low-actinic volumetric flask, add 50 mL of Mobile phase, and swirl to dissolve. Add 10.0 mL of Internal standard solution, dilute with Mobile phase to volume, and mix.

In line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution

Line 2 of Acceptance criteria: Change
Epimer A: 40.0%–51.0% on the dried basis

to:
Epimer A: 40.0%–51.0%

Line 5 of Chromatographic system: Change
Column: 4.0-mm x 25-cm; 5-µm packing L##¹
to:
Column: 4.0-mm x 25-cm; 5-µm packing L76
AND
Delete corresponding footnote: Available as Metrosep C4-250.

Line 1 of Aqueous potassium hydroxide solution: Change
Dissolve 800 mg of potassium hydroxide in 1000 mL of freshly boiled water, mix, and cool.
to:
Dissolve 800 g of potassium hydroxide in 1000 mL of freshly boiled water, mix, and cool.

Line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution

Line 1 of Standard solution: Change
Transfer 10 mg of USP Omeprazole RS to a 250-mL volumetric flask, and dissolve in about 10 mL of methanol.
to:
Transfer 10 mg of USP Omeprazole RS to a 250-mL volumetric flask, and dissolve in about 10 mL of alcohol.

Line 3 of Analysis: Change
Separately calculate the percentage of the labeled amount of sodium estrone sulfate and sodium equilin sulfate in the portion of Conjugated Estrogens taken:

to:
Separately calculate the percentage of the labeled amount of sodium estrone sulfate and sodium equilin sulfate in the portion of Tablets taken:

Line 1 of Standard solution: Change
1.0 µg/mL of USP Itraconazole RS in Diluent
to:
10.0 µg/mL of USP Itraconazole RS in Diluent

Line 4 of Chromatographic system: Delete
The flow rate is about 0.5 mL per minute.

Line 11 of Analysis: Change
C_U = concentration of olanzapine in the Sample solution (mg/mL)
to:
C_U = nominal concentration of olanzapine in the Sample solution (mg/mL)

Line 2: Change
10³
to:
10³ cfu/g
AND
Line 3: Change
10²
to:
10² cfu/g

Line 13 of Analysis: Change
0.5 N alcoholic potassium hydroxide
to:
0.5 N alcoholic potassium hydroxide VS

Line 5 of Analysis: Change
Result = (r_U/r_S) × (C_S/C_U) × (1/F) × 0.1
to:
Result = (r_U/r_S) × (C_S/C_U) × (1/F) × 100

Rows 11 and 15 of Column 2 of Table 2: Change
100
to:
10
AND
Rows 11 and 15 of Column 3 of Table 2: Change
10
to:
1.0
AND
Row 11 of Column 4 of Table 2: Change
1.5
to:
0.15
AND
Row 15 of Column 4 of Table 2: Change
30
to:
3.0

Row 13 of Column 4 of Table 2: Change
25
to:
1.0

Line 2 of Target Elements: Change
Pd
to:
Pb

Line 19: Change
25C(A_U/A_S)

to:
250C(A_U/A_S)

Change the subsection

Buffer and Diluent: Prepare as directed in the Assay.

to:

Diluent: Prepare as directed in the Assay.

Buffer: 6.8 g/L of monobasic potassium phosphate in
water. Adjust with phosphoric acid to a pH of 3.0.

Row 11 of Table 2: Change
3′-Demethyl-3′-N-[(4-methylphenyl)sulfonyl]azithromycin
to:
3′-N-Demethyl-3′-N-[(4-methylphenyl)sulfonyl]azithromycin